Who are BioCardia, Inc.'s main suppliers?

BioCardia, Inc. (BCDA) key suppliers include: H-C-WAINWRIGHT-CO-LLC, Myriad Genetics, Inc., Myriad Genetics, Inc.. View the full supplier network at chainsifter.com/chain/BCDA.

Who are BioCardia, Inc.'s major customers?

BioCardia, Inc. (BCDA) key customers include: Myriad Genetics, Inc., Myriad Genetics, Inc., BIOCARDIA-LIFESCIENCES-INC, CO-LLC. View the full customer network at chainsifter.com/chain/BCDA.

What sector is BioCardia, Inc. in?

BioCardia, Inc. (BCDA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

BioCardia, Inc. Supplier List (BCDA): 3 Verified Suppliers

3Suppliers

4Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

BioCardia, Inc. (BCDA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships

2Distinct source URLs

5High confidence

0.785Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

BioCardia, Inc. Suppliers

Ticker	Name	Confidence	Evidence
H-C-WAINWRIGHT-CO-LLC	H-C-WAINWRIGHT-CO-LLC	92%	At-the-Market (ATM) Offerings – On December 6, 2023, we entered into an “At The Market” offering agreement (the Sales Agreement) with H.C. Wainwright & Co., LLC (HCW).
MYGN	Myriad Genetics, Inc.	72%	interruption, our ability to manage our domestic and foreign operations could be impaired, which could materially and adversely affect our results of operations and financial condition. If a natural …
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from BCDA graph: interruption, our ability to manage our domestic and foreign operations could be impaired, which could materially and…

BioCardia, Inc. Customers

Ticker	Name	Confidence	Evidence
MYGN	Myriad Genetics, Inc.	72%	interruption, our ability to manage our domestic and foreign operations could be impaired, which could materially and adversely affect our results of operations and financial condition. If a natural …
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from BCDA graph: interruption, our ability to manage our domestic and foreign operations could be impaired, which could materially and…
BIOCARDIA-LIFESCIENCES-INC	BIOCARDIA-LIFESCIENCES-INC	62%	ordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ m…
CO-LLC	CO-LLC	62%	ent expense is made up of expenses for common area maintenance and shared utilities and were not included in the determination of the present value of lease payments. We have no finance leases. Our l…

BioCardia, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BCDA-DEBT-8094	Warrants outstanding: 296296	90%	xbrl warrant detail from xbrl 2026-03-31.
BCDA-DEBT-8095	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2019-12-31.
BCDA-DEBT	Debt stack $412,000	90%	Market cache reports total debt of $412,000.

BioCardia, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for BioCardia, Inc..

BioCardia, Inc. Ownership

Holder	Name	Confidence	Evidence
BCDA-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 18 tracked holders.

BioCardia, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
MYGN	Myriad Genetics, Inc.	100.00	1	['customer', 'supplier']
BNR	Burning Rock Biotech Limited	50.00	2
IMNM	Immunome, Inc.	50.00	2
PSNL	Personalis, Inc.	50.00	2
BNTC	Benitec Biopharma Inc.	50.00	2
CALC	CalciMedica, Inc.	50.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
SDGR	Schrödinger, Inc.	50.00	2
CABA	Cabaletta Bio, Inc.	50.00	2
ELVN	Enliven Therapeutics, Inc.	50.00	2
ATYR	aTyr Pharma, Inc.	50.00	2
BIAF	bioAffinity Technologies, Inc.	50.00	2
FLGT	Fulgent Genetics, Inc.	50.00	2
DSGN	Design Therapeutics, Inc.	50.00	2
HOWL	Werewolf Therapeutics, Inc.	50.00	2
TPST	Tempest Therapeutics, Inc.	50.00	2
GH	Guardant Health, Inc.	50.00	2
KDK	Kodiak AI, Inc.	50.00	2
BIOA	BioAge Labs, Inc.	50.00	2

BioCardia, Inc. Supply Chain